Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | EXEL | ROIV | ||
| Company | Intra-Cellular Ther | Exelixis Inc | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 84.54 | 33.30 | 11.47 | ||
| High | 85.03 | 33.68 | 11.67 | ||
| Low | 82.76 | 33.11 | 11.41 | ||
| Last | 83.45 | 33.29 | 11.57 | ||
| Change | -0.69 | -0.39 | +0.07 | ||
| % Change | -0.82% | -1.16% | +0.61% | ||
| Volume | 1,120,400 | 7,648,900 | 16,004,100 | ||
| 20-Day Average Volume | 482,575 | 2,140,510 | 5,387,515 | ||
| Previous Close | 84.14 | 33.68 | 11.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 85.00 | 35.34 | 12.17 | ||
| 20-Day Raw Stochastic | 26.84% | 4.66% | 10.49% | ||
| 20-Day Relative Strength | 49.15% | 46.91% | 44.56% | ||
| Weighted Alpha | +21.96 | +46.38 | +5.98 | ||
| Today's Opinion | 80% Buy | 56% Buy | 48% Buy | ||
| Previous Opinion | 80% Buy | 80% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.51% since 12/13/24 | -4.97% since 12/13/24 | -2.28% since 12/13/24 | ||
| Low | 82.19 on 12/16/24 | 33.11 on 12/20/24 | 11.41 on 12/20/24 | ||
| High | 89.12 on 12/18/24 | 36.22 on 12/16/24 | 12.22 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -2.56% since 11/20/24 | -3.92% since 11/20/24 | +0.70% since 11/20/24 | ||
| Low | 81.37 on 12/11/24 | 33.11 on 12/20/24 | 11.41 on 12/20/24 | ||
| High | 89.12 on 12/18/24 | 36.97 on 11/29/24 | 12.94 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +7.52% since 09/20/24 | +26.00% since 09/20/24 | -3.34% since 09/20/24 | ||
| Low | 70.90 on 10/07/24 | 25.17 on 10/10/24 | 11.05 on 11/18/24 | ||
| High | 93.45 on 11/11/24 | 36.97 on 11/29/24 | 12.94 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +10.46% since 06/20/24 | +53.20% since 06/20/24 | +7.13% since 06/20/24 | ||
| Low | 66.26 on 07/01/24 | 21.82 on 07/03/24 | 10.00 on 08/05/24 | ||
| High | 93.45 on 11/11/24 | 36.97 on 11/29/24 | 13.06 on 09/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,847,118 | 9,506,926 | 8,422,381 | ||
| Shares Outstanding, K | 106,017 | 285,579 | 727,950 | ||
| Annual Sales | 464,370,000 | 1,830,210,000 | 124,800,000 | ||
| Annual Net Income | -139,670,000 | 207,770,000 | 4,348,930,000 | ||
| Last Quarter Sales | 175,380,000 | 539,540,000 | 4,480,000 | ||
| Last Quarter Net Income | -26,320,000 | 117,970,000 | -230,180,000 | ||
| 60-Month Beta | 0.95 | 0.52 | 1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 10/30/24 | 0.47 on 10/29/24 | -0.29 on 11/12/24 | ||
| Latest Earnings Date | 10/30/24 | 02/04/25 | 02/11/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.87 | 0.00 | ||